Short-term outcomes of COVID-19 and risk factors for progression

作者：Long Li, Xiansheng Zeng, Xu Zhang, Wei Xiao, Ensong Guo, Wenzhi Zhan, Xuejiao Yang, Chunyan Li, Caiyun Wu, Tingting Xu, Chen Zhan, Yuehan Chen, Mei Jiang, Nanshan Zhong, Kefang Lai · 发表于：European Respiratory Journal · 年份：2020 · DOI：10.1183/13993003.00990-2020 · 被引用次数：69 · 研究领域：COVID-19 Clinical Research Studies、Long-Term Effects of COVID-19、COVID-19 and healthcare impacts

With a median (IQR ) follow-up time of 24.0 (17.5–30.0) days, progression occurred in 19.6% moderate, 27.8% severe and 66.7% critical COVID-19. Neutrophil-to-lymphocyte ratio ≥2.973, age ≥50 years, male sex and comorbidity were associated with progression. https://bit.ly/3crsJr0